Lee Si-Hyung, Lee Dong Gun, Yang Sung-Tae, Kim Yangmee, Kim Jae Il, Hahm Kyung-Soo, Shin Song Yub
Protein Engineering Laboratory, Korea Research Institute of Bioscience and Biotechnology, Yusong P.O. Box 115, Taejon, Korea.
Protein Pept Lett. 2002 Oct;9(5):395-402. doi: 10.2174/0929866023408535.
P18 (KWKLFKKIPKFLHLAKKF-NH(2)), an a-helical antimicrobial peptide designed from cecropin Amagainin 2 hybrid, was known to have potent antimicrobial activity against bacteria as well as fungi without hemolytic activity. To find the peptides comparable or superior to the antimicrobial activity of P18, the two reversed peptides (Rev-1 and Rev-2) of P18 were designed and synthesized. These peptides were found to have similar antimicrobial activity against bacterial and fungal cells without hemolytic activity as compared with P18. Furthermore, a reversed peptide, Rev-2 was shown to have a two-fold higher activity in killing some bacterial cells than P18. Therefore, these results suggested that Rev-2 peptide seems to be an excellent candidate for developing novel peptide antibiotics.
P18(KWKLFKKIPKFLHLAKKF-NH(2))是一种由天蚕素A马盖宁2杂交体设计的α-螺旋抗菌肽,已知其对细菌和真菌具有强大的抗菌活性,且无溶血活性。为了找到与P18抗菌活性相当或更优的肽,设计并合成了P18的两种反向肽(Rev-1和Rev-2)。与P18相比,这些肽对细菌和真菌细胞具有相似的抗菌活性且无溶血活性。此外,反向肽Rev-2在杀死某些细菌细胞方面的活性比P18高两倍。因此,这些结果表明Rev-2肽似乎是开发新型肽类抗生素的优秀候选物。